Related by context. Frequent words. (Click for all words.) 61 Private Placement Offering 61 Option Grants 61 Stock Repurchase 60 Shelf Registration Statement 60 Previously Announced 60 Warrant Exercise 60 Share Repurchases 60 Debt Tender Offer 59 Flow Through Offering 59 Merger Transaction 59 Compensation Expense 59 Non Controlling Interests 59 Fourth Quarter Dividend 58 -ABGL 58 Share Buyback Program 58 Announces Stockholder Approval 58 Subsequent Offering 58 Exclusive License 58 Completes Tender Offer 58 Summarizes 57 Monthly Dividends 57 Preferred Stock Dividends 57 Provides Guidance 57 Commence Trading 57 Annual Meeting Date 57 Extends Tender Offer 57 Share Repurchase 57 Stock Repurchase Plan 57 Review Initiated 57 Shareholder Approval 57 Provides Updates 56 Share Repurchase Plan 56 Private Placement Financing 56 Merger Related 56 Stock Buyback 56 Regains Compliance 56 Shareholder Letter 56 Explore Strategic Alternatives 56 Announces Issuance 56 Regains Compliance With 56 Dividend Payment 56 Non Recurring 56 Declares Distribution 56 -NIDC 56 #,#,# #,#,# -Uzi Dayan 56 Repricing 56 Common Share Offering 56 Debt Conversion 56 Preferred Dividends 55 Achieves Milestone 55 Cost Reductions 55 Issues Guidance 55 Cash Dividends 55 Wholly Owned 55 Complete Merger 55 Extends Offer 55 Updates Shareholders 55 Common Share Dividend 55 Commences Trading 55 Offering Quick Facts 55 CUSIP # [002] 55 SUBSEQUENT EVENTS 55 Convertible Debt 55 Completes Private Placement 55 Small Molecule 55 Income Tax Regs 55 Flow Through Financing 55 Based Compensation Expense 55 Dividends Declared 55 Completes Financing 55 -Cedomir Jovanovic 54 Vertex Pharmaceuticals Announces 54 Declares Increased 54 Goodwill Impairment 54 -vnunet.com 54 undistributed earnings 54 Notice Regarding 54 Related Expenses 54 Stockholders Approve 54 Supplementary Data 54 Disclosure Requirements 54 Stockholder Rights Plan 54 Announces Termination 54 Reporting Issuer 54 Patient Enrollment 54 Derivative liability 54 #.#/Share [002] 54 Compl 54 Repurchase Program 54 = Net [041] 54 = Basic [002] 54 Shareholder Vote 54 Preclinical Data 54 [014] 54 Subsequent Events 54 Period Ending 54 Buyback Program 54 Miscellaneous #.#.# Release 54 Reclassified 53 Fundamental Change 53 Related Costs